+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Functional expression and cellular distribution of diastrophic dysplasia sulfate transporter (DTDST) gene mutations in HEK cells



Functional expression and cellular distribution of diastrophic dysplasia sulfate transporter (DTDST) gene mutations in HEK cells



Human Molecular Genetics 13(19): 2165-2171



Defects in sulfate transport in chondrocytes lead to undersulfation of the cartilage extracellular matrix proteoglycans. Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene have been linked to four chondrodysplasias of varying severity. To characterize disease-causing mutations of DTDST, we expressed DTDST-mediated sulfate transport in mammalian HEK-293 cells and determined that the wild-type protein is glycosylated and localized to the cell plasma membrane. Four mutations, A715V, C653S, Q454P and R279W, stimulated sulfate transport at rates only 39-62% of wild-type DTDST. These four mutations were expressed on the plasma membrane of the cell, but the amount of expressed protein was reduced when compared with wild-type DTDST. The Q454P mutant is unique in that it is not properly glycosylated in HEK cells. There was no difference in sulfate transport activity between cells transfected with either the DeltaV340 or the G678V mutations and control HEK cells. Furthermore, the G678V mutation is not expressed along the plasma membrane, but is trapped within the cytoplasm. When comparing the sulfate transport capacity of each DTDST mutation with the chondrodysplasia in which it has been identified, we find that individuals with severe achondrogenesis 1B phenotype have null mutations on both DTDST alleles. Heterozygotes for both a null mutation and a partial-function mutation result in either atelosteogenesis type 2 or DTD, whereas the milder, recessive multiple epiphyseal dysplasia phenotype is homozygous for partial-function mutations. In contrast to previous studies in Xenopus laevis oocytes, we find a strong correlation between the severity of the phenotype and the level of residual transport function in mammalian cells.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012105798

Download citation: RISBibTeXText

PMID: 15294877

DOI: 10.1093/hmg/ddh242


Related references

Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype. Human Molecular Genetics 10(14): 1485-1490, 2001

Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance. Human Mutation 17(3): 159-171, 2001

Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias. American Journal of Human Genetics 58(2): 255-262, 1996

Diastrophic dysplasia sulfate transporter (DTDST) gene is not involved in pseudodiastrophic dysplasia. American Journal of Medical Genetics 73(4): 493-494, 1997

Diastrophic dysplasia sulfate transporter (Dtdst) gene is not involved in pseudodiastrophic dysplasia. American Journal of Medical Genetics 73(4): 493-494, 1997

Dysplastic spondylolysis is caused by mutations in the diastrophic dysplasia sulfate transporter gene. Proceedings of the National Academy of Sciences of the United States of America 112(26): 8064-8069, 2015

Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate transporter gene. American Journal of Human Genetics 57(4 Suppl. ): A48, 1995

A chondrodysplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations. American Journal of Medical Genetics 63(1): 144-147, 1996

A family of chondrodysplasias caused by mutations in the diastrophic dysplasia sulfate transporter gene and associated with impaired sulfation of proteoglycans. Annals of the new York Academy of Sciences 785: 195-201, 1996

Defective sulfation of proteoglycans in achondrogenesis type IB is caused by mutations in the DTDST gene The disorder is allelic to diastrophic dysplasia. American Journal of Human Genetics 57(4 Suppl. ): A48, 1995

A compound heterozygote of novel and recurrent DTDST mutations results in a novel intermediate phenotype of Desbuquois dysplasia, diastrophic dysplasia, and recessive form of multiple epiphyseal dysplasia. Journal of Human Genetics 53(8): 764-768, 2008

A phenotype intermediate between Desbuquois dysplasia and diastrophic dysplasia secondary to mutations in DTDST. American Journal of Medical Genetics. Part a 146a(22): 2920-2924, 2008

Recessive multiple epiphyseal dysplasia due to a homozygous R279W mutation of the DTDST gene Overlap with mild diastrophic dysplasia. Genetics in Medicine 4(3): 189, May-June, 2002

A novel mutation in the sulfate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia. Journal of Medical Genetics 45(12): 827-831, 2008

A compound heterozygote harboring novel and recurrent DTDST mutations with intermediate phenotype between atelosteogenesis type II and diastrophic dysplasia. American Journal of Medical Genetics. Part A 140(11): 1143-1147, 2006